Anzeige
Mehr »
Dienstag, 12.08.2025 - Börsentäglich über 12.000 News
Diese Aktie liegt in der Turbo-Zone - und könnte der Gold-Gewinner 2025/26 werden!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
23.06.Celltrion Opens UK Headquarters in Uxbridge
23.06.Cellular Origins, Johnson & Johnson Partner for CGT Robotics Manufacturing Platform
23.06.Nutriband, Kindeva Complete Commercial Scale-up for Aversa Fentanyl
23.06.Pharmalogic Acquires Majority Stake in Agilera Pharma
23.06.Formation Bio Licenses Gusacitinib to Sanofi
23.06.Harbour BioMed, Otsuka Partner to Advance Bispecific T-Cell Engagers
20.06.Ferring Opens New Gene Therapy Manufacturing Facility
20.06.Enzene Expands Biomanufacturing Operations at New Jersey Site
20.06.Sanner Launches Manufacturing Ops in Greensboro, NC
19.06.Kindeva, Rocket Science Health Create New Intranasal Delivery Platform
19.06.Delpharm Invests in Saint-Rémy Site to Support Aseptic Vials
19.06.LOTTE Biologics, Ottimo Pharma Sign Antibody Manufacturing Contract
19.06.RyboDyn Selected to Join Lilly Gateway Labs
19.06.Veranova Breaks Ground on ADC Facility Expansion
19.06.Bend Bioscience Opens Four New Process Development & Mfg. Suites in Oregon
19.06.Antares Vision Group Launches AI-Driven Visual Inspection Platform
18.06.Cellular Origins, Thermo Fischer Scientific Partner to Manufacture Industrial CGTs
18.06.Mabion Launches €500,000 Oncology Services Contest
18.06.Fareva Pilots New GMP Unit at Its Pau Site
17.06.Lifecore Biomedical Enters 10-Year Commercial Manufacturing & Supply Agreement with Existing Customer
16.06.Teva, Fosun Pharma Partner to Develop Immuno-Oncology Therapy
16.06.Anne Wojcicki's Nonprofit Tops Bid for 23andMe Assets
16.06.Ecolab Life Sciences Introduces New Resin
13.06.AstraZeneca, CSPC Pharmaceuticals Partner for Novel Oral Therapies
13.06.FDA Approves Keytruda for PD-L1+ as Neoadjuvant Treatment